Skip to main content

Table 1 Survivability of post-stroke patients based on risk factors hospitalized at Hospital Seberang Jaya using Kaplan-Meier analysis (n = 185)

From: Survivability of patients admitted for stroke in a primary stroke center, Penang, Malaysia: a retrospective 5-year study

Variables

Number of

Number of

Survivability (%)

p-valuea

Patients, n

Events,

2 days

4 days

6 days

8 days

10 days

n

Overall Survivability

185

25

94.7

88.0

76.4

63.1

50.5

 

Age category

       

0.905

 

≤ 61 years

95

13

94.4

87.7

75.6

61.9

51.6

 
 

≥ 62 years

90

12

96.7

95.0

88.3

69.6

52.2

 

Gender

        

0.895

 

Male

92

15

94.0

86.1

69.1

62.2

46.6

 
 

Female

68

13

96.4

91.8

78.7

65.6

32.8

 

Ethnicity

        

0.750

 

Malay

87

9

91.8

87.0

87.0

65.2

65.2

 
 

Chinese

64

10

89.9

85.1

61.3

49.0

0.0

 
 

Indian

25

3

75.0

75.0

75.0

50.0

0.0

 
 

Others

9

3

87.5

87.5

87.5

87.5

43.0

 

Smoking status

       

0.124

 

No

137

23

93.0

86.9

76.8

61.7

48.0

 
 

Yes

48

2

91.7

91.7

68.8

68.8

68.8

 

Stroke category

       

< 0.001*

 

Ischemic stroke

171

14

96.9

94.6

86.6

69.6

60.9

 
 

Hemorrhagic stroke

14

11

70.7

47.1

28.3

28.3

14.1

 

Stroke episode

       

< 0.001*

 

First

137

9

96.0

93.7

85.9

76.3

61.1

 
 

Recurrent

48

16

91.1

79.5

63.6

49.5

39.6

 

Number of comorbidities

       

0.136

 

≤ 2comorbidities

107

10

96.5

93.7

93.7

75.0

53.5

 
 

≥ 3comorbidities

78

15

92.5

82.7

61.9

53.1

26.5

 

Number of medications

       

0.118

 

≤ 10medications

103

10

94.2

83.7

73.2

73.2

0.0

 
 

≥ 11medications

82

15

95.6

90.6

79.0

68.5

60.8

 

Anti-platelets

       

0.014*

 

No

29

17

82.6

67.6

53.8

48.4

41.5

 
 

Yes

156

8

99.4

91.4

83.1

69.3

46.2

 

Statins

        

< 0.001*

 

No

33

18

84.0

67.4

49.1

35.1

28.1

 
 

Yes

152

7

97.1

92.5

85.9

85.9

68.7

 

Proton pump inhibitors

       

0.863

 

No

49

5

93.9

82.1

82.1

41.1

41.1

 
 

Yes

136

20

94.9

85.8

74.8

65.1

40.5

 

Anti-diabetic

       

0.266

 

No

112

18

93.6

85.6

70.3

57.5

41.1

 
 

Yes

73

7

96.4

91.8

71.4

71.4

35.7

 

Anti-hypertensive

       

0.046*

 

No

127

20

94.2

83.6

71.3

55.1

45.9

 
 

Yes

58

5

95.9

87.2

87.2

87.2

65.4

 

Anti-infective

       

0.005*

 

No

150

5

97.5

89.3

89.3

59.6

59.6

 
 

Yes

35

20

85.7

73.0

61.9

53.1

42.5

 
  1. Note: a survival analysis using Kaplan-Meier